{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-071749","form_type":"8-K","ticker":"SNDX","cik":"0001395937","company_name":"Syndax Pharmaceuticals Inc","filed_at":"2023-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.852899+00:00","generated_at":"2026-06-07T09:46:05.002975+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Syndax closes $230M public offering of common stock at $18.50/share","bullets":["Offering of 12,432,431 shares includes full exercise of underwriters' option to purchase 1,621,621 additional shares.","Gross proceeds of approximately $230M; net proceeds after underwriting discounts and expenses expected.","Post-offering shares outstanding as of Dec 19, 2023: 84,809,736.","Goldman Sachs, J.P. Morgan, TD Cowen, and Stifel acted as joint book-running managers.","Offering made under an existing effective shelf registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-071749","json":"https://secwatch.observer/filing/0000950170-23-071749.json","markdown":"https://secwatch.observer/filing/0000950170-23-071749.md","text":"https://secwatch.observer/filing/0000950170-23-071749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1395937/000095017023071749/0000950170-23-071749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1395937/000095017023071749/sndx-20231219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:46:05.002975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}